CROI 2017 Program and Information

Program and Agenda

THURSDAY, FEBRUARY 16, 2017

Plenary PL-3 THURSDAY PLENARY SESSION Auditorium - 4 AB

8:30 AM - 9:30 AM

Oral Sessions • Thursday 8:30 108 IF YOU CANMAKE IT THERE: ENDING THE HIV EPIDEMIC INNEWYORK Demetre C. Daskalakis , NYC DHMH, New York, NY, USA 109 HTLV-1: THE OTHER HUMAN RETROVIRUS Charles R. Bangham , Imperial Coll London, London, UK 9:00

Oral Abstract O-10 IMPROVING THE HIV CARE CASCADE Room 6 C

10:00 AM - 12:00 PM

Oral Abstract Moderators Loice Achieng , Univ of Nairobi, Nairobi, Kenya Valdilea Veloso , Oswaldo Cruz Foundation - Fiocruz, Rio de Janeiro, Brazil 110 A COMBINATION INTERVENTION STRATEGY FOR HIV LINKAGE AND RETENTION INMOZAMBIQUE Batya Elul 1 , Matthew R. Lamb 1 , Maria Lahuerta 1 , Fatima Abacassamo 2 , Laurence Ahoua 3 , Stephanie Kujawski 1 , Maria Tomo 2 , Ilesh Jani 4 1 Columbia Univ, New York, NY, USA, 2 Cntr for Collab in Hlth, Maputo City, Mozambique, 3 ICAP at Columbia Univ, Maputo City, Mozambique, 4 Inst Nacional de Saude, Maputo, Mozambique 111 PEER NAVIGATION ENHANCES HIV CARE RETENTION: AN RCT IN SOUTH AFRICAN PRIMARY CLINICS Wayne T. Steward 1 , Emily Agnew 1 , Julia DeKadt 2 , Hailey Gilmore 1 , Mary- Jane Ratlhagana 2 , Jessica Grignon 3 , Starley B. Shade 1 , John Tumbo 4 , Scott Barnhart 3 , Sheri A Lippman 1 1 Univ of California San Francisco, San Francisco, CA, USA, 2 Intl Training and Educ Cntr for Hlth–South Africa, Pretoria, South Africa, 3 Univ of Washington, Seattle, WA, USA, 4 Rustenburg Sub-District Office, Rustenburg, South Africa Andrew Phillips 1 , Valentina Cambiano 1 , Michael Jordan 2 , Fumiyo Nakagawa 1 , Marco Vitoria 3 , Meg Doherty 3 , Paul Revill 4 , Elliot Raizes 5 , Silvia Bertagnolio 4 , for the Working Group on Modelling Drug Resistance in Sub- Saharan Africa 1 Univ Coll London, London, UK, 2 Tufts Univ, Boston, MA, USA, 3 WHO, Geneva, Switzerland, 4 Univ of York, York, UK, 5 CDC, Atlanta, GA, USA 113 INCREASED RISK OF CART FAILURE AFTER LOW-LEVEL VIREMIA UNDERWHO GUIDELINES Lucas E. Hermans 1 , Michelle A. Moorhouse 2 , Sergio Carmona 2 , Diederick Grobbee 3 , Laura Marije Hofstra 3 , Douglas D. Richman 4 , Hugo Tempelman 5 , Willem D. Venter 2 , Annemarie Wensing 3 , for the Ndlovu Research Consortium 1 Univ Med Cntr Utrecht, Utrecht, Netherlands, 2 Univ of Witwatersrand, Johannesburg, South Africa, 3 Univ Med Cntr Utrecht, Utrecht, Netherlands, 4 Univ of California San Diego, San Diego, California, USA, 5 Ndlovu Care Group, Groblersdal, South Africa 10:00 10:15 10:30 10:45 112 COST-EFFECTIVENESS OF POLICY OPTIONSWHEN PRETREATMENT NNRTI DRUG RESISTANCE IS HIGH

CROI 2017 60